At a glance
- Originator Johnson & Johnson Pharmaceutical Research & Development
- Developer Johnson & Johnson Pharmaceutical Research & Development LLC
- Class Anti-inflammatories; Antirheumatics; Small molecules
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammatory bowel diseases; Psoriasis; Rheumatoid arthritis
Most Recent Events
- 15 Dec 1998 New profile
- 15 Dec 1998 Preclinical development for Inflammatory bowel disease in USA (Unknown route)
- 15 Dec 1998 Preclinical development for Psoriasis in USA (Unknown route)